Results 231 to 240 of about 2,674,072 (303)

Prescribing of GLP-1 and GIP/GLP-1 Receptor Agonists and Other Glucose-Lowering Drugs Requiring Special Caution in Elderly Japanese People With Type 2 Diabetes: A Preliminary Report. [PDF]

J Clin Med Res
Sato M, Takemura R, Yuki M, Saika T, Yamazaki M, Yamazaki T, Sakamoto M.   +6 more
europepmc   +1 more source

Impact of COVID‐19 restrictions and their relaxation on body composition and glycemic control in individuals with glucose intolerance in Japan: A single‐center observational study

Journal of Diabetes Investigation, Volume 17, Issue 6, Page 1063-1074, June 2026.
This study examined glycemic control, body composition, and lifestyle changes in 221 outpatients with glucose intolerance (GI) in Japan across the pre‐state of emergency (SOE), SOE, and post‐SOE periods. HbA1c increased despite body weight reduction, with progressive muscle loss.
Ami Kobayashi, Yamato Keidai, Takaaki Murakami, Ryo Tsukaguchi, Miharu Fujita, Keiko Wada, Daisuke Yabe   +6 more
wiley   +1 more source

A Remote Chronic Disease Management Program to Improve Cardiovascular and Metabolic Outcomes in a Diverse Community‐Based Diabetic Population: Study Design of the TAMIS Trial

Journal of Evaluation in Clinical Practice, Volume 32, Issue 4, June 2026.
ABSTRACT Introduction Cardiovascular and cerebrovascular diseases are projected to expand in the coming decades as the main cause of death. This study outlines the escalating burden of cardiovascular diseases in low‐ and middle‐income countries (LMICs), particularly in Latin America (LA), which is expected to surpass that of other high‐population ...
Renato de Carvalho Barros, Andrea Stephanus, José Antonio Barbosa Filho, Evellyn Mariana, Yasmim Botelho, Thaiene M. M. Severino, Robson Conceição Silva, Lucila de Jesus Almeida, Cristiane Koeche, Bruno Gedeon, Mariana Guimarães Souza de Oliveira, Ana Carolina Augusto, Catarina Ferraz, F. Enzo, Gabriela de Lima, Julia Andrade Ibiapina, Giselle Pinto, Sérgio Henrique Rodolpho Ramalho, Ana Claudia C. Nogueira, Andrei C. Sposito, Alessandra M. Campos‐Staffico, Alexandre Anderson S. M. Soares, Luiz Sérgio F. de Carvalho   +22 more
wiley   +1 more source

Discovery of novel quinazoline-sulfonamide derivatives with promising antidiabetic activity. [PDF]

Front Chem
Zayed MF, Muhammad Y, Alqurain AA, Banafa MAA, Omar AM.   +4 more
europepmc   +1 more source

Toxicological profile of anti-diabetic drugs and emerging measures to reduce the toxic burden. [PDF]

Toxicol Rep
Dugbartey GJ, Alornyo KK, Dapaa-Addo CO, Kwashie EK, Harley Y, Asiedu BN.   +5 more
europepmc   +1 more source

Sulfonylurea Receptor 2B and Klr6.1 Form a Sulfonylurea-Sensltive but ATP-insensltive K+ Channel

Japanese Journal of Pharmacology, 1997
Mitsuhiko Yamada, Shojiro Isomoto, Shiqeto Matsumoto, Chikako Kondo, Takashi Shindo, Yoshiyuki Horio, Yoshihlsa Kurachi   +6 more
openaire   +1 more source

Can diabetic peripheral neuropathy influence the final outcome of physical performance after a combined training program in older adults? A double‐blind quasi‐experimental study

Physiological Reports, Volume 14, Issue 11, June 2026.
Illustration of the main findings of the study. Abstract This study investigated the influence of diabetic peripheral neuropathy (DPN) on physical performance in older adults with type 2 diabetes mellitus (T2DM) following a combined training (CT) program. A total of 51 older adults participated in the study divided into DPN (n = 24) and non‐DPN (n = 27)
Matheus Henrique dos Santos Lino, Marcus Vinicius Grecco, Eneida Yuri Suda, Sara Rodrigues Rosado, André Luiz de Seixas Soares, Adriana Machado Saldiba de Lima, Guilherme Carlos Brech, Julia Maria D'Andréa Greve, Angelica Castilho Alonso   +8 more
wiley   +1 more source

Co-occurrence of Loss-of-Function GCK and ABCC8 Variants in a Pedigree With a Spectrum of Dysglycemia. [PDF]

Diabetes
Saint-Martin C, ElSheikh A, Jacqueminet S, Arnoux JB, Ciangura C, Bellanné-Chantelot C, Shyng SL.   +6 more
europepmc   +1 more source

Evaluation of %CV and average glucose derived from pre- and postprandial 6-point glucose measurements for assessing hypoglycemia risk. [PDF]

J Diabetes Investig
Soga R, Torimoto K, Uemura F, Okada Y, Nakayamada S.   +4 more
europepmc   +1 more source

The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. [PDF]

MedComm (2020)
Zou C, Jiang S, Li H, Zhao K, Cao D, Yang G.   +5 more
europepmc   +1 more source